Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

AMG 714 Expanded Access Program

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03439475
Expanded Access Status : Available
First Posted : February 20, 2018
Last Update Posted : March 4, 2019
Sponsor:
Information provided by (Responsible Party):
Amgen

Brief Summary:
Expanded access requests for AMG 714 may be considered for adult patients with biopsy proven Refractory Celiac Disease Type II who have failed all available treatment options and do not have EATL. To request access, use Responsible Party contact information provided in this record.

Condition or disease Intervention/treatment
Celiac Disease Biological: AMG 714

Layout table for study information
Study Type : Expanded Access
Expanded Access Type : Individual Patients
  See clinical trials of the intervention/treatment in this expanded access record.

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Celiac Disease



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Criteria

Inclusion Criteria:

-

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03439475


Contacts
Layout table for location contacts
Contact: Amgen Call Center 866-572-6436 medinfo@amgen.com

Sponsors and Collaborators
Amgen

Layout table for additonal information
Responsible Party: Amgen
ClinicalTrials.gov Identifier: NCT03439475     History of Changes
Other Study ID Numbers: AMG714 Expanded Access Program
First Posted: February 20, 2018    Key Record Dates
Last Update Posted: March 4, 2019
Last Verified: March 2019
Keywords provided by Amgen:
Refractory Celiac Disease Type II
Additional relevant MeSH terms:
Layout table for MeSH terms
Celiac Disease
Malabsorption Syndromes
Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases
Metabolic Diseases